News

28

May, 2019

Article – “R&D for children’s antibiotics: a wake-up call” published in AMR Control

Tags: , , ,

We are delighted to see  an article on children’s antibiotics, co-authored by GARDP R&D Director, Dr Seamus O’Brien, Penta’s Chief Scientific Officer, Prof. Theo Zakoutlis and Prof. Mike Sharland, from St. George’s, University of London, published in AMR Control, as governments have been discussing AMR at the World Health Assembly.

READ MORE

4

Mar, 2019

GARDP and Penta partner to accelerate the development of children’s antibiotics to tackle AMR

Tags: , ,

Penta have joined forces with GARDP (The Global Antibiotic Research & Development Partnership) to tackle drug-resistant infections in children. Our strategic collaboration aims to accelerate paediatric development of antibiotic treatments including: clinical trials designed to meet regulatory requirements; and trials with a focus on public health interventions to inform treatment guidelines.

READ MORE